Tectonic Therapeutic | AVRO - Pre Tax Profit

Stock Price
24.37
Daily Change
1.51 6.61%
Monthly
12.10%
Yearly
-33.14%
Q1 Forecast
19.37

Tectonic Therapeutic reported $-19.04M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Alnylam Pharmaceuticals USD 238.97M 274.33M Sep/2025
Celltrion KRW 14.6B 180.89B Jun/2025
Cspc Pharmaceutical CNY 1.21B 110.04M Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 9.12B 1.79B Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Kangmei Pharma CNY 2.07M 13.77M Sep/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -41.72M 25.52M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Pharma Mar EUR -4.08M 27.43M Sep/2025
Qiagen NV USD 134.73M 7.91M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Sarepta Therapeutics USD -194.05M 347.69M Sep/2025
Sartorius EUR 85M 14.1M Sep/2025
Takeda JPY 133.86B 105.69B Dec/2025
Tilray USD -1.39B 600.71M Mar/2025
Zz Pientze Pharmaceu CNY 523.11M 659.54M Jun/2025